Tahitian Noni International, Inc.

Morinda, Inc.

Bing-Nan Zhou

Afa Kehaati Palu

Stephen P Story

Chen Su

Claude Jarakae Jensen

Brett Justin West

Robert Ogden

Claude Jarake Jensen

Scott Gerson

Shixin Deng

C Jarakae Jensen

Richard G Godbee

Johannes Joseph Westendorf

Shixin Dong

Mian Ying Wang

John W Wadsworth

The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processedbased formulations.

[object Object]

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processedproduct that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processedproducts for a safe, pre-determined duration.

Selectively inhibiting estrogen production and providing estrogenic effects in the human body

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.

Methods and compositions relating to leaf extracts obtained fromleaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from theL. plant. Methods and compositions relating to leaf extract compositions comprising one or more of the leaf extracts and leaf serums.

The present invention advances prior art animal food products by providing an animal food product formulated with., or Mangosteen fruit, from the Mangosteen plant. The addition of Mangosteen to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.

The present invention relates to antifungal and antibacterial activity of processedproducts, as well as from various fractions of extracts from these processed products and the. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.

Growing community of inventors

Sandy, UT, United States of America

Bing-Nan Zhou